We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Live Cells Detect Food-Borne Pathogens, Toxins

By Labmedica staff writers
Posted on 11 Mar 2008
A new technology can simultaneously screen thousands of samples of food or water for several dangerous food-borne pathogens in one to two hours. More...
The technique also can estimate the amount of microbes present and whether they pose an active health risk. This could help neutralize potential threats and improve food-processing techniques.

The technology utilizes live mammalian cells that release a measurable amount of a signaling chemical when harmed. Optical equipment and computer software then analyze this quantity to estimate the amount of harmful microbes present. The technology can recognize very small amounts of Listeria monocytogenes; a bacterium that kills one in five infected, and is the leading cause of food-borne illness. It also recognizes several species of Bacillus, a non-fatal but common cause of food poisoning.

The cells are suspended in collagen gel, a substance that captures particles of a desired size, and put into small wells within multiwell plates. Each well can test one sample, so tests can be expanded to quickly analyze as many samples as desired. Because the technology tests for bacteria and toxins that attack cell membranes, cells are used with high amounts of alkaline phosphatase, the signaling chemical released upon damage to the cell membrane.

Samples of food and water are added to biosensor wells before being incubated for one to two hours. To each well a chemical is added that reacts with the biosensor's alkaline phosphatase, yielding a yellow product that is quantified by a special camera and a computer.

Actively harmful pathogens are identified whereas those that are inactive or harmless are ignored. Other tests lack this capability, making them prone to false alarms and entailing a relatively lengthy incubation period to culture any living microbes. The new technology's discerning power also could help optimize processes to kill harmful microbes or deactivate toxins.

The technique is versatile, and the multiwell plates and their contents of gel-suspended mammalian cells can be prepared in a central location. When desired, the plates could then be shipped to the test location, such as a food-processing plant, so that on-site analysis could take place.

The suspension of live mammalian cells within a collagen gel is unique, according to the scientists from Purdue University (West Lafayette, IN, USA) who developed the technique, which was described in the February 2008 issue of the journal Laboratory Investigation.


Related Links:
Purdue University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
HPV Test
Allplex HPV28 Detection
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.